KRAS(G12C) Coupled Nucleotide Exchange Assay Kit (Discontinued)

Catalog #
78004
$1,490 *
Catalog number 78004, KRAS(G12C) Coupled Nucleotide Exchange Assay Kit (Discontinued), has been discontinued. Please find our suggested alternative here.
Purchase
Description

The KRAS(G12C) Coupled Nucleotide Exchange Assay Kit is designed for screening and profiling of KRAS(G12C) antagonists/inhibitors by monitoring the binding of an effector protein (i.e. Ras binding domain of Raf1, RBD-cRaf) to KRAS(G12C). The KRAS(G12C) Coupled Nucleotide Exchange Assay Kit comes in a convenient 384-well format, with enough purified recombinant GDP-loaded KRAS(G12C) Isoform A, GTP, exchange factor SOS1, an effector protein RBD-cRAF, assay buffer and additives for 400 reactions. With this kit, a few simple steps on a microtiter plate are required for nucleotide exchange detection. First, a sample containing GDP-loaded KRAS(G12C) is incubated with SOS1 and GTP for the nucleotide exchange. Next, RBD-cRAF is added and incubated for the effector-RAS binding. Then, acceptor and donor beads are added and incubated for detection followed by reading the Alpha-counts.

SOS1 is a guanine nucleotide exchange factor that facilitates the exchange of GDP for GTP. GDP-loaded KRAS(G12C) is in an inactive state, and does not interact with the Ras-binding domain (RBD) of cRAF.  SOS1 assists in the release GDP from KRAS(G12C) so that GTP can occupy the nucleotide binding pocket. This results in a conformational change in KRAS(G12C) that permits binding of RBD-cRAF to KRAS(G12C). The KRAS(G12C) Coupled Nucleotide Exchange Assay Kit utilizes GST-tagged RBD-cRAF and His-tagged KRAS (G12C) to assay binding of KRAS(G12C) to RBD-cRAF in the Alpha assay. Glutathione acceptor and Ni chelate donor beads are brought into proximal range by the binding of KRAS(G12C) and RBD-cRAF, enabling the energy transfer from the donor to acceptor beads after laser excitation. 

SOS1 is a guanine nucleotide exchange factor that facilitates the exchange of GDP for GTP

Synonyms
C-K-RAS kit, CFC2 kit, K-RAS2A kit, Coupled Nucleotide Exchange Assay, SOS1 kit
Product Info
Storage and Usage
Citations
Assay Kit Format
AlphaLISA®
Supplied As
The KRAS(G12C) Coupled Nucleotide Exchange Assay Kit comes in a convenient 384-well format, with enough purified recombinant GDP-loaded KRAS(G12C) Isoform A, GTP, exchange factor SOS1, an effector protein RBD-cRAF, assay buffer and additives for 400 reactions
Materials Required But Not Supplied

AlphaLISA® Glutathione acceptor beads, 5 mg/ml (PerkinElmer #AL109C)
AlphaScreen® Nickel Chelate donor beads, 5 mg/ml (PerkinElmer #AS101D)
Optiplate -384 (PerkinElmer #6007290)
AlphaScreen® microplate reader
Adjustable micropipettor and sterile tips

Format
Catalog
Number
Name Amount Storage
100640 GDP loaded KRAS(G12C), Isoform A, His-tag* 10 μg -80°C
100753 SOS1, FLAG-Tag, Avi-Tag, Biotin-Labeled* 2 x 100 µg -80°C
100519 RBD-cRAF, GST-tag 5 µg -80°C
79861-2 GTP (10 mM) 0.5 ml -20°C
78351 RBD-RAS Binding Buffer 6 ml 4°C
79311 3x Immuno Buffer 1 4 ml -20°C

*The concentration of the protein is lot-specific and will be indicated on the tube.

UniProt #
P01116
Background

It is well established that RAS mutations are responsible for more than 30% of human cancers. KRAS(G12C) is one of the KRAS mutations that is found frequently in lung and colon cancers. The G12C mutation favors the activated (GTP-bound) state of KRAS, amplifying signaling pathways that lead to oncogenesis. Recent studies have led to the discovery of a small molecule called AMG510 (Amgen) that locks KRAS conformation in the GDP-bound (inactive) state, thereby blocking KRAS(G12C)-mediated signaling pathway.  Compounds that affect the nucleotide exchange (GDP to GTP) reaction could lead to a novel approach leading to the inhibition of tumor cell growth in KRAS(G12C) driven tumors.

References

1. Canon, J., et al. Nature 2019; 575:217-223.
2. Hillig, R.C., et al. 2019. PNAS USA 116 (7): 2551-2560